Soley Therapeutics
PrivateLast Round
Series C
Jan 7, 2026
Total Funding Raised
$290M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Soley Therapeutics is a biotechnology company that uses its proprietary cell stress-sensing platform, integrated with AI and automation, to discover and develop first-in-class medicines for oncology, neurodegenerative, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Soley Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Soley Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 7, 2026 | ||||
| Series A | Dec 22, 2020 |
Key People
Founding team and executive leadership
Soley Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Surveyor Capital | Series C |
| Breyer Capital | Series B, Series C, Series A |
| GordonMD Global Investments | Series B, Series C, Series A |
| HRTG Partners | Series C |
| RWN Management | Series C |
| Citadel | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Preclinical data for STX-6398 presented at AACR Annual Meeting 2026.
- Mar 18, 2026
STX-6398 targets undruggable CKAP2 for selective anti-tumor activity.
Soley Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Soley Therapeutics's valuation, stock price, and market status.